Pa. High Court's Design Ruling Revives Fen-Phen Suit

Law360, Philadelphia (February 28, 2014, 6:19 PM EST) -- The Pennsylvania Supreme Court said Friday that its recent opinion concluding that pharmaceutical companies can be held liable for negligence in the design and marketing of drugs merited a lower court's reconsideration of a decision nixing a product liability suit against a Pfizer Inc. unit over the diet drug fen-phen.

The justices issued a one-page summary disposition ordering the Superior Court to reconsider the case in light of the new standard set for negligence claims against pharmaceutical companies by the Supreme Court in Lance v. Wyeth...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.